News

DENVER, Colo. – The publication of the Eighth Edition of the Tumor, Node and Metastasis (TNM) Classification of Lung Cancer will provide physicians around the world access to new data to more precisely stage and treat cases of lung cancer. That data, collected by the International Association for the Study of Lung Cancer (IASLC) Staging and Prognostic Factors Committee and presented at the 16th World Conference on Lung Cancer (WCLC) in Denver on Tuesday, Sept. 8, 2015 at the Colorado Convention Center, will be published in 2016.

DENVER, Colo. — “Despite tremendous advances in treating lung cancer, there is still no specific, diagnostic approach available to treat women,” said Dr. Silvia Novello, Associate Professor, Department of Oncology, University of Turin-Italy. Dr. Novello made her remarks while opening the press briefing today at the 16th World Conference on Lung Cancer (WCLC) hosted by the International Association of the Study of Lung Cancer (IASLC), which covered many topics including a new edition of the TNM Staging System, the new WHO Classification on Tumors of the Lung and increases in the number of lung cancer in patients who never smoked.

The International Association for the Study of Lung Cancer (IASLC) will hold a press conference on Wednesday, Sept. 9, 2015 at 9:45 a.m. MDT to reveal findings from key abstracts detailing advances in lung cancer study and research. Full presentations of these abstracts and other lung cancer study advancements will take place throughout the 16th World Conference on Lung Cancer (WCLC).

DENVER, Colo. — Researchers expect that the administration of molecular-targeted therapies will be considered for the advanced-stage of adenocarcinoma in young lung cancer patients, according to a presentation by Dr. Kosuke Tanaka, department of Cancer Genetics, Nagoya University Graduate School of Medicine; Division of Molecular Oncology, Aichi Cancer Center Research Institute, Japan. Dr. Tanaka presented his data at 16th World Conference on Lung Cancer (WCLC) hosted by the International Association of the Study of Lung Cancer (IASLC) in Denver.

DENVER, Colo. — Research presented today shows that certain lung cancer patients under age 40 are associated with an increased chance for a targeted genomic alteration that may lead to more effective treatments. Dr. Barbara Gitlitz, Associate Professor of Clinical Medicine at the University of Southern California Keck School of Medicine in Los Angeles unveiled the findings at the 16th World Conference on Lung Cancer (WCLC) hosted by the International Association of the Study of Lung Cancer (IASLC).

DENVER, Colo. — The percentage of patients with non-small cell lung cancer (NSCLC) who never smoked is on the rise, according to a report conducted of lung cancer patients in three hospitals in Texas and Tennessee. Dr. Lorraine Pelosof, Assistant Professor, UT Southwestern Medical Center, Dallas, Texas presented the research at the 16th World Conference on Lung Cancer (WCLC) hosted by the International Association of the Study of Lung Cancer (IASLC).

Pages